samedan logo
 
 
 
spacer
home > pmps > summer 2003 > combating internet distribution of counterfeit pharmaceuticals
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Combating Internet Distribution of Counterfeit Pharmaceuticals

Suspect distribution of pharmaceuticals online provides an ideal outlet for rogue manufacturers to sell counterfeit medications to the unsuspecting public with a high degree of anonymity. Internet pharmacies offer privacy, convenience and low prices. The combined impacts on consumer safety and pharmaceutical firms' profitability from Internet-supplied counterfeit products could be devastating.

According to a study prepared for this article, leading pharmaceutical brands promoted heavily online are exposed to suspect distribution on the Internet. This intelligence about suspect distribution of major branded pharmaceutical products is a key indicator of exposure to counterfeit risks. The sample set of five brands examines over 8,000 different websites for product promotions that appeal to lifestyle users or those that may self medicate. The research has also identified links between suspect distribution and extreme Internet activities such as pornography and gambling.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Kristofer Peterson, Internet Intelligence Consultant at New Vantage Limited

Kristofer Peterson is Internet Intelligence Consultant at New Vantage. He has been working in the Internet intelligence sector for nearly three years, initially with Infonic and then with Cyveillance. During this time he has developed expertise in the ways in which Internet exposure can present both challenges and opportunities for major corporations, and the ways this exposure may be tracked and managed. Kristofer studied Business at the London School of Economics following receipt of a BA in Politics from Whitman College in the US.

spacer
Kristofer Peterson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sartorius Stedim Biotech Launches New Services for Mammalian Cell Bank Manufacturing

GOETTINGEN, Germany and GLASGOW, UK, August 08, 2019 / B3C newswire / -- Sartorius Stedim Biotech (SSB), a leading partner of the biopharmaceutical industry, today announced the launch of new services for mammalian cell bank manufacture under GMP conditions. These services are offered by its subsidiary, Sartorius Stedim BioOutsource, an experienced contract testing organization (CTO) based in Glasgow, UK, and in Cambridge, Massachusetts, USA.
More info >>

White Papers

Clinical Trial-Specific Travel Programs as a Patient Retention Tool

For many patients, participating in a clinical trial is a major endeavor. Depending on the protocol requirements, study visits can be exhausting. There are a number of reasons why a patient may choose to participate in a trial only to drop out. Conversely, there are several approaches to proactively try to prevent this from happening. There are various methods professionals implement for patient retention. This white paper explores patient travel services as one patient retention strategy.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement